Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MICAL2 mRNA | decreases expression | 19933214
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of MICAL2 mRNA | affects expression | 17562736
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of MICAL2 mRNA | decreases expression | 19150397
|
D004317 |
Doxorubicin |
MICAL2 protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of MICAL2 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D011374 |
Progesterone |
Progesterone results in decreased expression of MICAL2 mRNA | decreases expression | 18070364
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of MICAL2 mRNA | decreases expression | 19933214
|
C025643 |
vinclozolin |
vinclozolin affects the expression of MICAL2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 11752688 14514962 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
2.61 | 17418594 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.05 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.05 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.83 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.22 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.83 | 19015723 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.59 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.59 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
5.08 | 14601052 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.71 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.56 | 15845082 15665606 15380490 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
4.04 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
1.91 | 15567936 15993339 16096432 15634643 19526202 17369602 15939500 18382427 17426702 16595493 15136595 16826403 16264153 16115903 18695136 15668708 16935488 17983394 18234424 16322301 15692762 15994142 11325840 18628466 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.91 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.91 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.19 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
3.08 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
3.08 | 17876044 18059187 16023760 16234567 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.26 | 1485588 16201981 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.69 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 16120746 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.68 | 17329180 15792986 16269455 16612575 18627295 16952015 17351982 17974986 17308081 15811867 16731534 17519947 15476868 16455267 16651473 16278810 17928571 17924179 15505089 17382496 16109756 17007740 17131338 16242529 16364871 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
3.01 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.71 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.88 | 20889678 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.00 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 15668235 15340226 16354765 8697196 12621046 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.62 | 14966744 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.80 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.53 | 10915739 11739529 11287661 12153990 14725611 15619225 16781746 17562736 19739265 16177239 11529661 14550746 12705907 12594235 17906064 16109766 15968718 12392966 12958197 10663392 18071297 16485898 11461765 16393943 17522070 19923254 19416960 19085960 11421492 11743745 11834606 10774834 14986274 16081117 16227642 18713872 19164858 19420014 2444490 19370779 12540782 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.53 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.53 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.47 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.70 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.70 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.35 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.35 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
4.06 | 17692515 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.60 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
9.70 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
9.70 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.53 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.12 | 20426865 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.01 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.93 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.05 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.27 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.68 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.49 | 17150277 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.68 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.64 | 16707910 16495754 17888722 18006777 18674790 16879835 16330681 17875725 16144979 16244372 16244371 14766674 12587719 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.51 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.51 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.14 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.30 | 19772884 18467677 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.30 | 15340226 12621046 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.62 | 17606976 18501091 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.89 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18670907 18850075 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.71 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.19 | 16467254 |
MESH:D007249 |
Inflammation |
|
Progesterone |
5.35 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.35 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.48 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
6.48 | 16775033 15699352 15369732 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.40 | 16707910 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.53 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
5.07 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.57 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.57 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.57 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.67 | 19460945 16610002 19014921 16611625 19784758 12587719 12969438 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.46 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.51 | 15890375 16377806 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.51 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
6.38 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.38 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.45 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.45 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.63 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.99 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.87 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.72 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.72 | 17203775 11408345 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.31 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.87 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.14 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.74 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
5.13 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
6.00 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
6.00 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.03 | 18259882 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.05 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
5.08 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.21 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.37 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.07 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.31 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
2.58 | 17393432 16525653 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.59 | 16870215 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.53 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.53 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.64 | 11896295 11399792 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
10.64 | 19015723 18220299 18042343 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.27 | 18220299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.51 | 16729912 15749863 16888761 16868541 15897917 18437689 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.27 | 18629315 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.53 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.92 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.22 | 15625365 18313854 16767912 17710206 15675481 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.52 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
5.13 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
6.02 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.02 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.87 | 16767912 17203757 15625365 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.62 | 15862959 16503802 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.55 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.84 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.24 | 10982225 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.53 | 17638931 17678736 16364871 17334414 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |